Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...
MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...
Peptides, as versatile biomolecules, continue to gain traction in various scientific fields due to their wide range of biochemical and physiological impacts. Among these, ABP-7 peptide has emerged as ...
News Medical on MSN3d
Gene therapy breakthrough offers hope for severe Dravet syndrome casesAAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...
AZoLifeSciences on MSN1h
Targeting NMDA Receptor Subunit Shows Promise for Fragile X SyndromeBuilding on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...
Cyrano Therapeutics, Inc., a clinical-stage regenerative medicine company pioneering the development of treatments for smell loss, announced today that on February 14, 2025 it entered into an option ...
Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...
Cells are constantly on the move, whether in a developing embryo or metastatic cancer. But how do cells adapt to the new ...
Messenger RNA can travel between different types of stem cells through tunnel-like structures, as revealed by a new study. By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback